AORT Artivion, Inc. Common Stock
NYSE · Health Care · SEC EDGAR で表示 ↗ 終値 10月 2, 2026 10-K/10-Q 8月 7, 2026
$22.31
· 52週範囲の%
· 安値より上
· 高値へ
$19.1652週安値
$48.2552週高値
時価総額 (MRQ)
$1.12B
P/E (TTM)
-371.8
EPS (TTM)
$-0.06
収益 (TTM)
$471M
あなたのバッジ
52週レンジ
$19–$48
アナリスト評価
BUY
目標株価
$42
P/E
-371.8
ROE
-0.73%
純利益率
-0.67%
バッジストリップは空です。このページ上の任意の指標をピン留めしてください。
AORT 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$22.31
時価総額 (MRQ)
$1.12B
P/E (TTM)
-371.8
EPS (TTM)
$-0.06
収益 (TTM)
$471M
ROE (TTM)
-0.73%
負債/自己資本 (MRQ)
0.8
52週レンジ
$19–$48
AORT 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
範囲
バー
バーの粒度は選択した期間に合わせて調整されます。バーの始値/高値/安値/終値を確認するにはチャートにカーソルを合わせてください。
株式分割
| 権利落ち日 | 分割 | タイプ |
|---|---|---|
| 2000年12月28日 | 3-for-2 | 順 |
| 1996年7月1日 | 2-for-1 | 順 |
Artivion, Inc. Common Stock について Wikipediaからの企業概要
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
## History
Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.
In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.
In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.
In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.
In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.
In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.
In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
セクターHealth Care
業種Health Care
従業員1,800
国US
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益$441M2016-12-31 → 2025-12-31
EPS$0.212016-12-31 → 2025-12-31
フリーキャッシュフロー$839.0K2016-12-31 → 2025-12-31
純利益率-0.67%2016-12-31 → 2025-12-31
バリュエーションと指標
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
| 指標 | 5年トレンド | AORT | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| P/E (TTM) | -371.85年平均 ≈5.0 | ≈5.0 | · | · | |
| P/S (TTM) | 2.45年平均 ≈3.0 | ≈3.0 | 3.9 | 割安 | |
| 株価純資産倍率 (MRQ) | 2.55年平均 ≈3.4 | ≈3.4 | 3.9 | 割安 | |
| EV / EBITDA (EV/EBITDA) | 22.55年平均 ≈32.6 | ≈32.6 | · | · | |
| 株価FCF倍率 (TTM) | -122.35年平均 ≈554.3 | ≈554.3 | · | · | |
| 株価収益率（P/CF） (TTM) | 26.85年平均 ≈-54.3 | ≈-54.3 | 38.0 | 割高 | |
| EV / Revenue (EV/売上高) | 2.95年平均 ≈3.7 | ≈3.7 | · | · | |
| EV / FCF (EV/FCF) | 1508.15年平均 ≈592.1 | ≈592.1 | · | · | |
| 株価純資産倍率（P/TB） (MRQ) | 3.8 | · | · | · |
同業他社の中央値は、指標ごとに標準化された基準で計算されており、この銘柄に表示されているTTM/MRQ基準と常に一致するとは限りません。
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
| 指標 | 5年トレンド | AORT | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| 粗利益率 (TTM) | 64.4%5年平均 ≈64.8% | ≈64.8% | 64.0% | 同水準 | |
| 営業利益率 (TTM) | 4.4%5年平均 ≈4.8% | ≈4.8% | -7.6% | 同水準 | |
| EBITDAマージン (TTM) | 9.6%5年平均 ≈11.4% | ≈11.4% | -7.6% | 同水準 | |
| 税引前利益率 (TTM) | 0.47%5年平均 ≈-2.9% | ≈-2.9% | -8.7% | 同水準 | |
| 純利益率 (TTM) | -0.67%5年平均 ≈-4.2% | ≈-4.2% | -9.5% | 同水準 | |
| ROA (TTM) | -0.33%5年平均 ≈-1.8% | ≈-1.8% | -20.2% | トップクラス | |
| ROE (TTM) | -0.73%5年平均 ≈-5.1% | ≈-5.1% | -25.1% | トップクラス | |
| ROIC | 3.4%5年平均 ≈3.8% | ≈3.8% | -31.3% | トップクラス |
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
| 指標 | 5年トレンド | AORT | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| 負債資本倍率 (MRQ) | 0.85年平均 ≈1.0 | ≈1.0 | 0.6 | 高負債 | |
| 流動比率 (MRQ) | 3.55年平均 ≈4.6 | ≈4.6 | 5.6 | 低流動性 | |
| Quick Ratio (クイックレシオ) | 1.55年平均 ≈2.0 | ≈2.0 | 3.6 | 低流動性 | |
| 長期負債/株主資本 (MRQ) | 0.85年平均 ≈1.0 | ≈1.0 | 0.6 | 高負債 |
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
| 指標 | 5年トレンド | AORT | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| Revenue YoY (収益（前年比）) | 13.6%5年平均 ≈11.8% | ≈11.8% | · | · | |
| Revenue CAGR 3Y (収益（3年CAGR）) | 12.0%5年平均 ≈11.0% | ≈11.0% | · | · | |
| Revenue CAGR 5Y (収益（5年CAGR）) | 11.8% | · | · | · |
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
| 指標 | 5年トレンド | AORT | 5年平均 | 競合中央値 | 結論 |
|---|---|---|---|---|---|
| Asset Turnover (総資産回転率) | 0.55年平均 ≈0.5 | ≈0.5 | 0.5 | 同水準 | |
| Inventory Turnover (棚卸資産回転率) | 1.85年平均 ≈1.6 | ≈1.6 | 1.8 | 同水準 | |
| Receivables Turnover (売掛金回転率) | 5.25年平均 ≈5.4 | ≈5.4 | 6.9 | 弱い | |
| Revenue / Employee (年間売上高 ÷ 従業員数（yfinanceの報告ヘッドカウント）。派生値 — SEC-XBRLの保存概念ではありません。) | ≈$245.2K | · | · | · |
バリュエーション · ≈ 5年平均 · 業界中央値 · 中央値に対する評価
配当金 利回り、配当性向、配当履歴、5年CAGR
年次配当≈$0.12
| 権利落ち日 | 金額 | 通貨 | 利回り |
|---|---|---|---|
| 12月 9, 2015 | $0.03 | USD | ≈1.2% |
| 9月 9, 2015 | $0.03 | USD | ≈1.2% |
| 6月 10, 2015 | $0.03 | USD | ≈1.1% |
| 3月 11, 2015 | $0.03 | USD | ≈1.2% |
| 12月 10, 2014 | $0.03 | USD | ≈1.1% |
| 9月 10, 2014 | $0.03 | USD | ≈1.2% |
| 6月 11, 2014 | $0.03 | USD | ≈1.3% |
| 3月 12, 2014 | $0.03 | USD | ≈1.2% |
| 12月 11, 2013 | $0.03 | USD | ≈1.1% |
| 9月 11, 2013 | $0.03 | USD | ≈1.7% |
| 6月 12, 2013 | $0.03 | USD | ≈1.7% |
| 3月 12, 2013 | $0.03 | USD | ≈1.2% |
| 12月 12, 2012 | $0.03 | USD | ≈0.83% |
| 9月 12, 2012 | $0.03 | USD | ≈0.45% |
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
-518.1%
次回決算
11月 04, 2026
| 期間 | レポート | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|---|
| 2026年6月30日 | 8月 5, 2026 | $-0.28 | $0.01 | -2845.1% |
| 2026年3月31日 | $0.03 | $0.05 | -40.1% | |
| 2025年12月31日 | $0.05 | $0.08 | -40.0% | |
| 2025年9月30日 | $0.06 | $0.02 | 242.9% | |
| 2025年6月30日 | $0.08 | $-0.00 | — | |
| 2025年3月31日 | $-0.01 | $-0.12 | 91.7% |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Cost of Revenue | $157M | $140M | $125M | $111M | $101M | $85M | $93M | $90M | $61M | $61M | $55M | $53M | |
| Gross Profit | $284M | $249M | $229M | $203M | $198M | $168M | $183M | $173M | $129M | $119M | $91M | $91M | |
| R&D Expense | $31M | $28M | $29M | $39M | $36M | $24M | $23M | $23M | $19M | $13M | $10M | $9M | |
| SG&A Expense | $226M | $181M | $209M | $157M | $170M | $141M | $143M | $141M | $101M | $92M | $75M | $74M | |
| Operating Expenses | $257M | $210M | $238M | $196M | $205M | $165M | $166M | $164M | $121M | $105M | $85M | $82M | |
| Operating Income | $34M | $39M | $6M | $6M | $8M | $2M | $17M | $9M | $8M | $22M | $5M | $9M | |
| Interest Expense | · | · | $25M | $18M | $17M | $17M | $15M | $16M | $5M | $3M | $62.0K | $175.0K | |
| Interest Income | $763.0K | $1M | $1M | $147.0K | $79.0K | $217.0K | $738.0K | $226.0K | $212.0K | $72.0K | $45.0K | $50.0K | |
| Other Non-op | $10M | $-10M | $-3M | $-3M | $-6M | $-3M | $-1M | $-141.0K | $260.0K | $-437.0K | $-484.0K | $-540.0K | |
| Pretax Income | $15M | $-8M | $-22M | $-15M | $-15M | $-17M | $2M | $-6M | $4M | $18M | $6M | $9M | |
| Income Tax | $5M | $6M | $9M | $4M | $7.0K | $-492.0K | $-76.0K | $-4M | $-143.0K | $8M | $2M | $1M | |
| Net Income | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| EPS (Basic) | $0.22 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.33 | $0.14 | $0.26 | |
| EPS (Diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 | |
| Shares (Basic) | 45,335,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,118,000 | 36,412,000 | 33,008,000 | 31,855,000 | 27,744,000 | 27,379,000 | |
| Shares (Diluted) | 47,162,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,860,000 | 36,412,000 | 34,163,000 | 32,822,000 | 28,542,000 | 28,313,000 | |
| EBITDA | $56M | $63M | $29M | $29M | $32M | $23M | $35M | $27M | $18M | $30M | · | $15M |
貸借対照表
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $53M | $59M | $39M | $55M | $61M | $34M | $41M | $40M | $57M | $38M | $33M | |
| Receivables | $90M | $79M | $72M | $62M | $53M | $46M | $53M | $47M | $48M | $28M | $23M | $21M | |
| Inventory | $92M | $80M | $82M | $74M | $77M | $73M | $53M | $45M | $47M | $26M | $15M | $13M | |
| Prepaid Expense | $43M | $19M | $16M | $18M | $15M | $14M | $12M | $7M | $5M | $3M | $5M | $5M | |
| Current Assets | $358M | $290M | $281M | $247M | $248M | $235M | $187M | $179M | $179M | $147M | $110M | $106M | |
| PP&E (Net) | $65M | $36M | $38M | $39M | $38M | $33M | $32M | $31M | $34M | $19M | $11M | $12M | |
| PP&E (Gross) | · | · | · | $127M | $120M | $111M | $103M | $96M | $93M | $74M | $64M | $62M | |
| Accum. Depreciation | · | · | · | $88M | $82M | $78M | $71M | $65M | $60M | $55M | $53M | $50M | |
| Goodwill | $254M | $241M | $247M | $244M | $250M | $260M | $187M | $189M | $188M | $78M | $11M | $11M | |
| Intangibles | $124M | $128M | $143M | $151M | $167M | $186M | $115M | $118M | $130M | $1M | $1M | $2M | |
| Other Non-current Assets | $15M | $24M | $9M | $7M | $8M | $15M | $14M | $8M | $7M | $2M | $6M | $5M | |
| Total Assets | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Accounts Payable | $16M | $18M | $13M | $12M | $10M | $10M | $10M | $8M | $10M | $6M | $5M | $4M | |
| Accrued Liabilities | $16M | $12M | $10M | $12M | $8M | $7M | $7M | $7M | $12M | $5M | $3M | $3M | |
| Current Liabilities | $102M | $67M | $58M | $50M | $45M | $60M | $45M | $35M | $43M | $30M | $20M | $21M | |
| Capital Leases | $34M | $40M | $44M | $41M | $45M | $14M | $18M | $0 | $7M | $11.0K | · | · | |
| Deferred Tax | $24M | $20M | $22M | $24M | $29M | $35M | $26M | $27M | $30M | $7.0K | · | · | |
| Other Non-current Liabilities | $9M | $8M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $5M | $3M | $3M | |
| Total Liabilities | $437M | $513M | $511M | $478M | $492M | $461M | $320M | $296M | $313M | $107M | $26M | $27M | |
| Long-term Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Total Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Common Stock | $493.0K | $434.0K | $426.0K | $418.0K | $414.0K | $404.0K | $390.0K | $385.0K | $376.0K | $342.0K | $298.0K | $292.0K | |
| Retained Earnings | $-51M | $-61M | $-48M | $-17M | $2M | $20M | $37M | $35M | $38M | $34M | $23M | $23M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $13M | $12M | $11M | $9M | |
| AOCI | $-3M | $-25M | $-12M | $-22M | $-10M | $7M | $-9M | $-6M | $2M | $-429.0K | $-76.0K | $-121.0K | |
| Stockholders' Equity | $448M | $276M | $282M | $284M | $301M | $329M | $286M | $275M | $277M | $209M | $155M | $149M | |
| Liabilities + Equity | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Shares Outstanding | 49,330,000 | 43,432,000 | 42,569,000 | 41,830,000 | 41,397,000 | 40,394,000 | 39,018,000 | 38,463,000 | 37,618,000 | 34,230,000 | 29,766,000 | 29,229,000 |
キャッシュフロー
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $24M | $23M | $22M | $24M | $21M | $18M | $18M | $10M | $8M | $6M | $6M | |
| Stock-based Comp | $24M | $14M | $14M | $12M | $11M | $7M | $9M | $6M | $7M | $6M | $5M | $3M | |
| Deferred Tax | $37.0K | $-2M | $-1M | $-885.0K | $-6M | $816.0K | $-2M | $-6M | $-1M | $3M | $1M | $173.0K | |
| Amort. of Intangibles | $14M | $16M | $15M | $15M | $17M | $14M | $11M | $11M | $5M | $4M | $2M | $2M | |
| Other Non-cash | $-17M | $-1M | $13M | $-20M | $-17M | $611.0K | $-11M | $-5M | $-8M | $-8M | · | $-9M | |
| Operating Cash Flow | $40M | $22M | $19M | $-5M | $-3M | $12M | $16M | $10M | $11M | $20M | $11M | $8M | |
| CapEx | $39M | $11M | $10M | $11M | $13M | $7M | $8M | $6M | $7M | $6M | $3M | $4M | |
| Investing Cash Flow | $-42M | $-28M | $-502.0K | $-11M | $6M | $-73M | $-24M | $-7M | $-171M | $-79M | $-4M | · | |
| Debt Issued | $0 | $184M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $-210.0K | $-28M | $-3M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | $2M | $3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Net Stock Activity | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | · | $-3M | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $3M | $3M | |
| Financing Cash Flow | $11M | $2M | $865.0K | $-2M | $-12M | $94M | $-1M | $-3M | $143M | $73M | $-3M | · | |
| Net Change in Cash | $11M | $-5M | $20M | $-16M | $-7M | $28M | $-8M | $1M | $-17M | $14M | $4M | $-4M | |
| Taxes Paid | $3M | · | · | · | · | · | · | · | · | · | $145.0K | $3M | |
| Free Cash Flow | $839.0K | $11M | $11M | $-14M | $-16M | $5M | $8M | $4M | $4M | $14M | · | $4M | |
| Levered FCF | · | · | $-25M | $-38M | $-33M | $-11M | $-8M | $-3M | $-925.8K | $12M | · | · |
収益性
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | 66.3% | 66.3% | 65.8% | 67.8% | 65.9% | · | 63.1% | |
| Operating Margin | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% | 0.96% | 6.2% | 3.5% | 4.2% | 12.1% | · | 6.1% | |
| Net Margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% | -6.6% | 0.62% | -1.1% | 1.9% | 6.0% | · | 5.1% | |
| Pretax Margin | 3.4% | -1.9% | -6.1% | -4.8% | -5.0% | -6.8% | 0.60% | -2.4% | 1.9% | 10.2% | · | 6.0% | |
| EBITDA Margin | 12.7% | 16.2% | 8.1% | 9.1% | 10.7% | 9.1% | 12.8% | 10.4% | 9.3% | 16.7% | · | 10.3% | |
| ROA | 1.2% | -1.7% | -4.0% | -2.5% | -1.9% | -2.4% | 0.29% | -0.49% | 0.82% | 4.3% | · | 4.2% | |
| ROE | 2.2% | -4.6% | -11.1% | -7.1% | -4.9% | -5.1% | 0.61% | -1.0% | 1.5% | 5.9% | · | 5.0% | |
| ROIC | 3.4% | 11.7% | 1.4% | 1.3% | 1.3% | 0.38% | 3.6% | 0.84% | 1.7% | 4.5% | · | 5.0% |
流動性と支払能力
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 | 3.9 | 4.1 | 5.2 | 4.2 | 4.9 | · | 5.1 | |
| Quick Ratio | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 | 1.8 | 1.9 | 2.6 | 2.0 | 2.8 | · | 2.6 | |
| Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| LT Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| Interest Coverage | · | · | 0.2 | 0.3 | 0.5 | 0.1 | 1.1 | 0.6 | 1.6 | 7.3 | · | · |
効率性
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.7 | · | 0.8 | |
| Inventory Turnover | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.4 | 1.9 | 1.9 | 1.7 | 3.0 | · | 4.7 | |
| Receivables Turnover | 5.2 | 5.1 | 5.3 | 5.5 | 6.0 | 5.1 | 5.5 | 5.6 | 5.0 | 7.0 | · | 7.4 |
1株あたり
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $9.09 | $6.36 | $6.62 | $6.80 | $7.26 | $8.14 | $7.32 | $7.15 | $7.37 | $6.11 | · | $5.09 | |
| Revenue / Share | $9.36 | $9.32 | $8.69 | $7.84 | $7.67 | $6.69 | $7.30 | $7.22 | $5.55 | $5.50 | · | $5.11 | |
| Cash Flow / Share | $0.85 | $0.53 | $0.46 | $-0.13 | $-0.07 | $0.33 | $0.42 | $0.27 | $0.32 | $0.60 | · | $0.29 | |
| Cash / Share | $1.32 | $1.23 | $1.38 | $0.94 | $1.33 | $1.52 | $0.87 | $1.08 | $1.06 | $1.65 | · | $1.14 | |
| Dividend / Share | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.12 | $0.12 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | $0.12 | $0.12 | |
| EPS (TTM) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 |
成長率
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.0% | 9.1% | 11.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM）
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Net Income TTM | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| Market Cap | $2.25B | $1.24B | $761M | $507M | $842M | $954M | $1.06B | $1.09B | $720M | $656M | · | $331M | |
| Enterprise Value | $2.40B | $1.50B | $1.01B | $776M | $1.10B | $1.18B | $1.24B | $1.27B | $899M | $670M | · | · | |
| P/E | 217.2 | -89.3 | -23.8 | -25.2 | -53.6 | -53.7 | 541.8 | -354.8 | 174.1 | 59.8 | 77.0 | 45.3 | |
| P/S | 5.1 | 3.2 | 2.2 | 1.6 | 2.8 | 3.8 | 3.8 | 4.2 | 3.8 | 3.6 | · | 2.3 | |
| P/B | 5.0 | 4.5 | 2.7 | 1.8 | 2.8 | 2.9 | 3.7 | 4.0 | 2.6 | 3.1 | · | 2.2 | |
| P / Tangible Book | 31.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 56.4 | 55.8 | 40.4 | -98.4 | -325.9 | 77.1 | 66.8 | 110.5 | 66.7 | 33.2 | · | 40.8 | |
| P / FCF | 2681.7 | 112.4 | 66.8 | -35.8 | -53.7 | 189.2 | 136.3 | 266.6 | 172.7 | 48.5 | · | 87.0 | |
| EV / EBITDA | 42.7 | 23.8 | 35.0 | 27.1 | 34.2 | 51.1 | 35.0 | 46.2 | 50.8 | 22.2 | · | · | |
| EV / FCF | 2860.7 | 136.0 | 88.6 | -54.7 | -70.0 | 234.9 | 159.8 | 309.4 | 215.6 | 49.6 | · | · | |
| EV / Revenue | 5.4 | 3.9 | 2.9 | 2.5 | 3.7 | 4.7 | 4.5 | 4.8 | 4.7 | 3.7 | · | · | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.99% | |
| Earnings Yield | 0.46% | -1.1% | -4.2% | -4.0% | -1.9% | -1.9% | 0.18% | -0.28% | 0.57% | 1.7% | 1.3% | 2.2% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | 45.0% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $3M | $3M |
損益計算書
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $126M | $116M | $116M | $113M | $113M | $99M | $97M | $96M | $98M | $97M | $94M | $88M | $89M | $83M | $79M | $77M | |
| Cost of Revenue | $45M | $41M | $43M | $39M | $40M | $35M | $36M | $35M | $35M | $34M | $33M | $32M | $31M | $30M | $29M | $28M | |
| Gross Profit | $81M | $75M | $73M | $74M | $73M | $64M | $62M | $61M | $63M | $63M | $61M | $56M | $58M | $54M | $51M | $49M | |
| R&D Expense | $9M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $6M | $7M | $7M | $8M | $12M | |
| SG&A Expense | $80M | $61M | $57M | $57M | $58M | $55M | $51M | $50M | $49M | $31M | $50M | $51M | $57M | $50M | $38M | $41M | |
| Operating Expenses | $89M | $70M | $66M | $65M | $65M | $61M | $59M | $57M | $57M | $38M | $58M | $58M | $65M | $58M | $47M | $53M | |
| Operating Income | $-8M | $6M | $11M | $13M | $8M | $2M | $3M | $4M | $7M | $25M | $3M | $-1M | $8M | $-4M | $4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $7M | $6M | $6M | · | $5M | |
| Interest Income | $367.0K | $205.0K | $311.0K | $240.0K | $68.0K | $144.0K | $374.0K | $366.0K | $353.0K | $374.0K | $398.0K | $339.0K | $265.0K | $75.0K | $61.0K | $40.0K | |
| Other Non-op | $4M | $-286.0K | $1M | $399.0K | $5M | $3M | $-10M | $2M | $-983.0K | $-1M | $2M | $-2M | $-4M | $963.0K | $4M | $-4M | |
| Pretax Income | $-12M | $339.0K | $7M | $7M | $3M | $-2M | $-17M | $-1M | $-2M | $13M | $-591.0K | $-9M | $-3M | $-9M | $3M | $-13M | |
| Income Tax | $2M | $-1M | $4M | $554.0K | $2M | $-2M | $-119.0K | $1M | $-306.0K | $5M | $3M | $382.0K | $725.0K | $5M | $1M | $1M | |
| Net Income | $-14M | $1M | $2M | $7M | $1M | $-505.0K | $-16M | $-2M | $-2M | $8M | $-4M | $-10M | $-3M | $-14M | $2M | $-14M | |
| EPS (Basic) | $-0.28 | $0.03 | $0.06 | $0.14 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| EPS (Diluted) | $-0.28 | $0.03 | $0.06 | $0.13 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| Shares (Basic) | 48,541,000 | 48,074,000 | · | 47,233,000 | 44,296,000 | 42,232,000 | · | 41,844,000 | 41,683,000 | 41,290,000 | · | 40,881,000 | 40,755,000 | 40,432,000 | · | 40,115,000 | |
| Shares (Diluted) | 48,541,000 | 49,731,000 | · | 48,775,000 | 45,378,000 | 42,232,000 | · | 41,844,000 | 41,683,000 | 47,886,000 | · | 40,881,000 | 40,755,000 | 40,432,000 | · | 40,115,000 | |
| EBITDA | $-8M | $12M | · | $13M | $8M | $8M | · | $4M | $7M | $31M | · | $-1M | $8M | $2M | · | $-4M |
貸借対照表
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $56M | $65M | $73M | $53M | $38M | $53M | $56M | $55M | $51M | · | $53M | $49M | $31M | · | $38M | |
| Receivables | $98M | $92M | $90M | $88M | $91M | $88M | $79M | $76M | $74M | $74M | · | $64M | $65M | $63M | · | $57M | |
| Inventory | $103M | $98M | $92M | $91M | $87M | $82M | $80M | $84M | $81M | $82M | · | $79M | $78M | $76M | · | $73M | |
| Prepaid Expense | $27M | $45M | $43M | $22M | $25M | $20M | $19M | $19M | $20M | $17M | · | $17M | $19M | $20M | · | $17M | |
| Current Assets | $371M | $358M | $358M | $337M | $319M | $287M | $290M | $288M | $285M | $277M | · | $267M | $264M | $241M | · | $238M | |
| PP&E (Net) | $74M | $68M | $65M | $41M | $40M | $38M | $36M | $38M | $37M | $38M | · | $37M | $38M | $39M | · | $36M | |
| Goodwill | $350M | $252M | $254M | $254M | $254M | $245M | $241M | $249M | $244M | $245M | $247M | $243M | $246M | $246M | $244M | $235M | |
| Intangibles | $149M | $120M | $124M | $126M | $129M | $128M | $128M | $135M | $135M | $138M | · | $143M | $147M | $150M | · | $148M | |
| Other Non-current Assets | $15M | $16M | $15M | $29M | $27M | $25M | $24M | $21M | $14M | $13M | · | $8M | $8M | $8M | · | $7M | |
| Total Assets | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Accounts Payable | $21M | $18M | $16M | $16M | $19M | $12M | $18M | $11M | $12M | $10M | · | $11M | $10M | $9M | · | $11M | |
| Accrued Liabilities | $16M | $17M | $16M | $12M | $11M | $12M | $12M | $16M | $16M | $16M | · | $10M | $10M | $10M | · | $10M | |
| Current Liabilities | $107M | $93M | $102M | $86M | $67M | $52M | $67M | $153M | $51M | $46M | · | $55M | $56M | $44M | · | $46M | |
| Capital Leases | $36M | $34M | $34M | $38M | $39M | $39M | $40M | $41M | $42M | $43M | · | $43M | $40M | $41M | · | $41M | |
| Deferred Tax | $26M | $28M | $24M | $22M | $23M | $22M | $20M | $19M | $22M | $22M | · | $20M | $19M | $24M | · | $34M | |
| Other Non-current Liabilities | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Total Liabilities | $626M | $433M | $437M | $419M | $418M | $497M | $513M | $498M | $494M | $489M | · | $503M | $495M | $477M | · | $488M | |
| Long-term Debt | $363M | $215M | $215M | $215M | $216M | $315M | $314M | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Total Debt | $363M | $215M | · | $215M | $216M | $315M | · | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Common Stock | $502.0K | $500.0K | $493.0K | $488.0K | $486.0K | $442.0K | $434.0K | $434.0K | $433.0K | $432.0K | · | $425.0K | $424.0K | $424.0K | · | $418.0K | |
| Retained Earnings | $-64M | $-50M | $-51M | $-54M | $-60M | $-62M | $-61M | $-45M | $-42M | $-40M | · | $-44M | $-34M | $-31M | · | $-19M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $15M | $15M | $15M | · | $15M | |
| AOCI | $-12M | $-12M | $-3M | $-2M | $-3M | $-19M | $-25M | $-10M | $-16M | $-14M | · | $-21M | $-16M | $-18M | · | $-45M | |
| Stockholders' Equity | $446M | $450M | $448M | $439M | $420M | $294M | $276M | $305M | $295M | $295M | $282M | $272M | $283M | $280M | $284M | $255M | |
| Liabilities + Equity | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Shares Outstanding | 50,179,000 | 49,983,000 | 49,330,000 | 48,862,000 | 48,592,000 | 44,190,000 | 43,432,000 | 43,392,000 | · | · | 42,569,000 | 42,537,000 | 42,443,000 | 42,366,000 | 41,830,000 | 41,816,000 |
キャッシュフロー
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $6M | |
| Stock-based Comp | $8M | $8M | $4M | $6M | $6M | $8M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | $3M | · | · | · | $6M | · | · | · | · | · | |
| Amort. of Intangibles | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | $-15M | · | · | · | $-30M | · | · | · | $-22M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-1M | $1M | $20M | $22M | $15M | $-17M | $10M | $11M | $6M | $-5M | $11M | $7M | $7M | $-6M | $-217.0K | $4M | |
| CapEx | $11M | $8M | $28M | $5M | $3M | $4M | $1M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Investing Cash Flow | $-129M | $-11M | $-31M | $-5M | $-3M | $-4M | $-11M | $-11M | $-3M | $-4M | $-3M | $-2M | $7M | $-3M | $-3M | $-3M | |
| Debt Issued | · | · | $0 | $0 | $0 | $0 | $-6M | $160M | $160M | $190M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | $0 | · | · | · | $-66.0K | · | · | · | $-182M | · | · | · | · | · | · | |
| Stock Issued | $1M | $1M | $3M | $5M | $278.0K | $4M | $443.0K | $2M | $59.0K | $4M | $488.0K | $886.0K | $0 | $3M | $24.0K | $1M | |
| Net Stock Activity | · | $1M | · | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | |
| Financing Cash Flow | $152M | $463.0K | $2M | $2M | $3M | $4M | $174.0K | $1M | $-181.0K | $737.0K | $-2M | $-909.0K | $2M | $1M | $-859.0K | $252.0K | |
| Net Change in Cash | $22M | $-9M | $-9M | $20M | $16M | $-16M | $-3M | $1M | $4M | $-8M | $5M | $5M | $18M | $-9M | $2M | $-3M | |
| Free Cash Flow | · | $-7M | · | · | · | $-21M | · | · | · | $-9M | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-18M | · | · |
収益性
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0% | 64.8% | · | 65.6% | 64.7% | 64.2% | · | 63.7% | 64.6% | 64.6% | · | 64.0% | 65.1% | 64.5% | · | 63.4% | |
| Operating Margin | -6.7% | 5.0% | · | 11.1% | 7.4% | 2.2% | · | 4.6% | 6.6% | 26.0% | · | -1.4% | 8.6% | -4.6% | · | -5.3% | |
| Net Margin | -10.7% | 1.2% | · | 5.7% | 1.2% | -0.51% | · | -2.4% | -2.2% | 7.7% | · | -11.2% | -3.8% | -16.3% | · | -17.8% | |
| Pretax Margin | -9.3% | 0.29% | · | 6.2% | 3.1% | -2.3% | · | -1.3% | -2.5% | 13.1% | · | -10.7% | -3.0% | -10.7% | · | -16.3% | |
| EBITDA Margin | -6.7% | 10.4% | · | 11.1% | 7.4% | 7.7% | · | 4.6% | 6.6% | 32.0% | · | -1.4% | 8.6% | 2.2% | · | -5.3% | |
| ROA | -1.4% | 0.17% | · | 0.78% | 0.17% | -0.06% | · | -0.29% | -0.27% | 0.98% | · | -1.3% | -0.44% | -1.8% | · | -1.8% | |
| ROE | -3.1% | 0.38% | · | 1.8% | 0.38% | -0.17% | · | -0.79% | -0.73% | 2.6% | · | -3.7% | -1.2% | -4.7% | · | -4.8% | |
| ROIC | -1.2% | 3.6% | · | 1.8% | 0.51% | 0.08% | · | 1.3% | 0.93% | 2.5% | · | -0.22% | 1.7% | -1.0% | · | -0.80% |
流動性と支払能力
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.9 | · | 3.9 | 4.8 | 5.5 | · | 1.9 | 5.6 | 6.0 | · | 4.9 | 4.7 | 5.5 | · | 5.2 | |
| Quick Ratio | 1.6 | 1.6 | · | 1.9 | 2.2 | 2.4 | · | 0.9 | 2.5 | 2.7 | · | 2.1 | 2.0 | 2.1 | · | 2.1 | |
| Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| LT Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 0.7 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | -0.2 | 1.2 | -0.6 | · | -0.9 |
効率性
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 |
1株あたり
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.88 | $9.01 | · | $8.98 | $8.64 | $6.66 | · | $7.02 | · | · | · | $6.39 | $6.66 | $6.61 | · | $6.10 | |
| Revenue / Share | $2.59 | $2.34 | · | $2.32 | $2.49 | $2.34 | · | $2.29 | $2.35 | $2.03 | · | $2.15 | $2.19 | $2.06 | · | $1.92 | |
| Cash Flow / Share | · | $0.02 | · | · | · | $-0.40 | · | · | · | $-0.11 | · | · | · | $-0.15 | · | · | |
| Cash / Share | $1.54 | $1.12 | · | $1.50 | $1.10 | $0.85 | · | $1.29 | · | · | · | $1.26 | $1.15 | $0.73 | · | $0.90 | |
| EPS (TTM) | $-0.06 | $0.25 | · | $-0.25 | $-0.43 | $-0.51 | · | $-0.02 | $-0.21 | $-0.24 | · | $-0.60 | $-0.70 | $-0.73 | · | $-1.03 |
バリュエーション（TTM）
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $471M | $459M | · | $423M | $405M | $390M | · | $385M | $377M | $368M | · | $340M | $329M | $320M | · | $314M | |
| Net Income TTM | $-3M | $12M | · | $-9M | $-18M | $-21M | · | $-851.0K | $-8M | $-10M | · | $-25M | $-28M | $-29M | · | $-41M | |
| Market Cap | $1.13B | $1.83B | · | $2.07B | $1.51B | $1.09B | · | $1.16B | · | · | · | $645M | $730M | $555M | · | $579M | |
| Enterprise Value | $1.41B | $1.99B | · | $2.21B | $1.67B | $1.36B | · | $1.41B | · | · | · | $899M | $988M | $832M | · | $849M | |
| P/E | -374.5 | 146.5 | · | -169.4 | -72.3 | -48.2 | · | -1331.0 | -122.1 | -88.2 | · | -25.3 | -24.6 | -17.9 | · | -13.4 | |
| P/S | 2.4 | 4.0 | · | 4.9 | 3.7 | 2.8 | · | 3.0 | · | · | · | 1.9 | 2.2 | 1.7 | · | 1.8 | |
| P/B | 2.5 | 4.1 | · | 4.7 | 3.6 | 3.7 | · | 3.8 | · | · | · | 2.4 | 2.6 | 2.0 | · | 2.3 | |
| P / Tangible Book | · | 23.2 | · | 35.5 | 41.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 1586.1 | · | · | · | -64.1 | · | · | · | · | · | · | · | -90.2 | · | · | |
| EV / Revenue | 3.0 | 4.3 | · | 5.2 | 4.1 | 3.5 | · | 3.7 | · | · | · | 2.6 | 3.0 | 2.6 | · | 2.7 | |
| Dividend Yield | 0.30% | 0.19% | · | 0.16% | 0.23% | 0.31% | · | 0.30% | · | · | · | 0.53% | 0.47% | 0.61% | · | 0.59% | |
| Earnings Yield | -0.27% | 0.68% | · | -0.59% | -1.4% | -2.1% | · | -0.08% | -0.82% | -1.1% | · | -4.0% | -4.1% | -5.6% | · | -7.4% | |
| Annual Payout | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M |
最新期間は左側 · null値は・として表示
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
| 指標 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 収益 | $441M | $389M | $354M | $314M | $299M |
| 粗利益率 % | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% |
| 営業利益率 % | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% |
| 純利益 | $10M | $-13M | $-31M | $-19M | $-15M |
| 希薄化後EPS | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
| 指標 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 負債資本倍率 | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 |
| 流動比率 | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 |
| クイックレシオ | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 |
| 指標 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $839.0K | $11M | $11M | $-14M | $-16M |
機関投資家（13F） 212 提出者 · $1.2B合計 · 時点 2026年9月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
保有者
212
保有価値
$1.2B
新規ポジション
34
解消済みポジション
65
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 34 (-7 前期比) | 65 (+29 前期比) | 81 (-12 前期比) | 56 (-7 前期比) | +2.0M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| BlackRock, Inc. | $149,965,153 | 6,674,017 | 12.78% | 株式数 |
| VANGUARD GROUP INC | $144,587,760 | 3,170,089 | 12.33% | 株式数 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $71,566,000 | 3,184,974 | 6.10% | 株式数 |
| MORGAN STANLEY | $57,477,400 | 2,557,961 | 4.90% | 株式数 |
| Juniper Investment Company, LLC | $45,386,816 | 2,019,885 | 3.87% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $45,043,789 | 2,004,619 | 3.84% | 株式数 |
| FMR LLC | $44,119,203 | 1,963,471 | 3.76% | 株式数 |
| STATE STREET CORP | $41,750,406 | 1,858,051 | 3.56% | 株式数 |
| Ophir Asset Management Pty Ltd | $40,446,180 | 1,800,008 | 3.45% | 株式数 |
| PERCEPTIVE ADVISORS LLC | $39,036,906 | 1,737,290 | 3.33% | 株式数 |
| Conestoga Capital Advisors, LLC | $36,484,539 | 1,623,700 | 3.11% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $28,318,470 | 1,260,279 | 2.41% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $25,043,403 | 1,114,297 | 2.13% | 株式数 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $23,011,325 | 1,024,091 | 1.96% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22,205,281 | 988,219 | 1.89% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $21,300,127 | 947,941 | 1.82% | 株式数 |
| CITADEL ADVISORS LLC | $18,596,037 | 827,594 | 1.59% | 株式数 |
| YARGER WEALTH STRATEGIES, LLC | $15,278,432 | 634,223 | 1.30% | 株式数 |
| ROYCE & ASSOCIATES LP | $14,364,667 | 639,282 | 1.22% | 株式数 |
| NORTHERN TRUST CORP | $12,370,454 | 550,532 | 1.05% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $11,716,689 | 521,437 | 1.00% | 株式数 |
| Qube Research & Technologies Ltd | $10,704,820 | 476,405 | 0.91% | 株式数 |
| FRED ALGER MANAGEMENT, LLC | $10,406,104 | 463,111 | 0.89% | 株式数 |
| UBS Group AG | $10,210,390 | 454,401 | 0.87% | 株式数 |
| TWO SIGMA ADVISERS, LP | $9,974,907 | 218,700 | 0.85% | 株式数 |
| Invesco Ltd. | $9,956,839 | 443,117 | 0.85% | 株式数 |
| GOLDMAN SACHS GROUP INC | $9,857,903 | 438,714 | 0.84% | 株式数 |
| D. E. Shaw & Co., Inc. | $9,846,714 | 438,216 | 0.84% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9,183,579 | 408,704 | 0.78% | 株式数 |
| Toroso Investments, LLC | $9,018,146 | 197,723 | 0.77% | 株式数 |
| Soleus Capital Management, L.P. | $8,718,360 | 388,000 | 0.74% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $8,702,159 | 387,279 | 0.74% | 株式数 |
| Balyasny Asset Management L.P. | $8,584,686 | 382,051 | 0.73% | 株式数 |
| First Eagle Investment Management, LLC | $7,787,496 | 346,573 | 0.66% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $6,978,103 | 310,552 | 0.59% | 株式数 |
| KENNEDY CAPITAL MANAGEMENT LLC | $6,611,371 | 294,231 | 0.56% | 株式数 |
| Legal & General Group Plc | $5,826,427 | 259,298 | 0.50% | 株式数 |
| WASATCH ADVISORS LP | $5,726,929 | 156,388 | 0.49% | 株式数 |
| PRINCIPAL FINANCIAL GROUP INC | $5,705,178 | 253,902 | 0.49% | 株式数 |
| Bank of New York Mellon Corp | $5,671,109 | 252,386 | 0.48% | 株式数 |
| Quantinno Capital Management LP | $4,497,191 | 200,142 | 0.38% | 株式数 |
| AMERIPRISE FINANCIAL INC | $4,348,978 | 193,546 | 0.37% | 株式数 |
| FIFTH THIRD BANCORP | $4,170,912 | 185,621 | 0.36% | 株式数 |
| ORBIMED ADVISORS LLC | $3,932,250 | 175,000 | 0.34% | 株式数 |
| Corient Private Wealth LP | $3,580,552 | 159,348 | 0.31% | 株式数 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $3,324,253 | 90,777 | 0.28% | 株式数 |
| Public Sector Pension Investment Board | $3,298,304 | 146,787 | 0.28% | 株式数 |
| Parkman Healthcare Partners LLC | $3,121,982 | 138,940 | 0.27% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2,879,149 | 128,133 | 0.25% | 株式数 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2,857,263 | 127,159 | 0.24% | 株式数 |
アクティビストおよび5%超のオーナー 5保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 提出書類 | 2025年8月12日 | 4.00% | 修正 | · | SEC |
| CryoLife, Inc., CL Falcon, Inc. | 2011年5月11日 | · | 初回提出 | M&A / 売却 | SEC |
| Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k) | 2007年7月10日 | · | 初回提出 | · | SEC |
| 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者, 未開示の報告者 | 2005年12月2日 | · | 初回提出 | 受動的投資 | SEC |
| 未開示の報告者 | 2005年3月18日 | · | 初回提出 | 受動的投資 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
企業インサイダー 49 人のインサイダー · 30人の役員 · 15人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| James P Mackin | President & CEO | 2026年8月19日 S | 877,275 | 0 | 9 | $-9,722,946 |
| Lance A Berry | EVP, COO, CFO & Treasurer | 2026年8月14日 S | 210,112 | 0 | 5 | $-803,205 |
| David Ashley Lee | Executive VP, COO & CFO | 2023年3月2日 S | 347,217 | 0 | 0 | $0 |
| Andrew M Green | SVP, Regulatory and Quality | 2026年9月10日 S | 40,160 | 0 | 6 | $-1,431,215 |
| Jean F Holloway | SVP, General Counsel | 2026年8月12日 S | 184,118 | 0 | 13 | $-2,537,794 |
| Marshall S. Stanton | SVP, Clinical & MD Affair | 2026年3月3日 S | 60,097 | 0 | 13 | $-3,426,956 |
| John E Davis | Chief Commercial Officer | 2026年3月3日 S | 230,794 | 0 | 9 | $-1,745,924 |
| Amy Horton | VP, Chief Accounting Officer | 2026年3月3日 S | 139,088 | 0 | 8 | $-870,080 |
| Matthew A Getz | VP, Human Resources | 2024年8月16日 S | 34,116 | 0 | 0 | $0 |
| Florian Tyrs | VP, Global Operations | 2024年2月27日 S | 21,558 | 0 | 0 | $0 |
| Rochelle L. Maney | VP, Quality | 2024年2月26日 S | 44,518 | 0 | 0 | $0 |
| Robert C Thomson | VP Research & Development | 2024年2月23日 A | 13,291 | 0 | 0 | $0 |
| Dennis B Maier | SVP, Operations | 2023年6月6日 S | 34,724 | 0 | 0 | $0 |
| Franz Peter Barthold | VP, Research & Development | 2022年11月8日 A | 32,516 | 0 | 0 | $0 |
| Scott B Capps | VP, Clinical Research | 2021年3月12日 F | 153,203 | 0 | 0 | $0 |
| James M Mcdermid | SVP, CHRO | 2019年3月14日 F | 30,806 | 0 | 0 | $0 |
| Sherry M Saurini | VP, Quality | 2019年3月14日 F | 25,084 | 0 | 0 | $0 |
| William Robert Matthews | Senior VP, Operations, Quality | 2018年3月5日 F | 39,883 | 0 | 0 | $0 |
| David C Gale | VP, Research & Development | 2017年11月16日 M | 77,135 | 0 | 0 | $0 |
| Steven G Anderson | Former Executive Chairman | 2015年4月9日 F | 1,271,846 | 0 | 0 | $0 |
| Bruce G. Anderson | VP, US Sales &Global Marketing | 2015年3月7日 F | 42,106 | 0 | 0 | $0 |
| FRONK DAVID | VP, Regulatory Affairs | 2015年3月7日 F | 110,559 | 0 | 0 | $0 |
| David P. Lang | VP, Int'l Sales & Marketing | 2015年2月26日 A | 73,441 | 0 | 0 | $0 |
| Jeffrey W Burris | Vice President & Gen. Counsel | 2014年8月15日 M | 95,221 | 0 | 0 | $0 |
| Gerald B Seery | Sr. VP, Sales and Marketing | 2012年11月30日 S | 71,999 | 0 | 0 | $0 |
| Albert E Heacox | Sr. VP Research and Devl | 2011年12月31日 F | 110,144 | 0 | 0 | $0 |
| Philip A Theodore | VP, General Counsel | 2007年9月4日 A | 23,100 | 0 | 0 | $0 |
| Sidney B Ashmore | Vice President of Marketing | 2006年1月18日 M | 42,728 | 0 | 0 | $0 |
| Kirby S Black | Sr. Vice President, R&D | 2004年9月21日 M | 55,131 | 0 | 0 | $0 |
| Vander James C Wyk | VP - Product Integrity | 2004年9月14日 M | 36,165 | 0 | 0 | $0 |
| Anthony B. Semedo | 取締役 | 2026年6月2日 J | 6,325 | 0 | 0 | $0 |
| Elizabeth A Hoff | 取締役 | 2026年5月18日 A | 34,765 | 0 | 1 | $-189,420 |
| Marna P Borgstrom | 取締役 | 2026年5月18日 A | 56,664 | 0 | 0 | $0 |
| Jon W Salveson | 取締役 | 2026年5月18日 A | 137,416 | 0 | 0 | $0 |
| Jeffrey H Burbank | 取締役 | 2026年5月18日 A | 61,372 | 0 | 0 | $0 |
| Daniel J Bevevino | 取締役 | 2026年5月18日 A | 157,637 | 0 | 0 | $0 |
| Bullock James | 取締役 | 2026年5月18日 A | 76,223 | 0 | 0 | $0 |
| Thomas F Ackerman | 取締役 | 2026年5月18日 A | 157,472 | 0 | 0 | $0 |
| Harvey Morgan | 取締役 | 2021年8月30日 G | 46,342 | 0 | 0 | $0 |
| Ronald D Mccall | 取締役 | 2021年8月25日 S | 121,768 | 0 | 0 | $0 |
| Elkins C Ronald | 取締役 | 2018年9月5日 S | 64,843 | 0 | 0 | $0 |
| James Benson | 取締役 | 2017年10月2日 S | 54,086 | 0 | 0 | $0 |
| John M Cook | 取締役 | 2009年6月9日 M | 85,000 | 0 | 0 | $0 |
| LACY VIRGINIA C | 取締役 | 2007年4月24日 S | 255,280 | 0 | 0 | $0 |
| VAN DYNE BRUCE J MD | 取締役 | 2006年8月1日 A | 12,800 | 0 | 0 | $0 |
| OSS CAPITAL MANAGEMENT | 10%オーナー | 2007年5月31日 S | 1,918,000 | 0 | 0 | $0 |
| Michael S Simpson | · | 2021年3月5日 F | 33,698 | 0 | 0 | $0 |
| Thomas J Bogenschuetz | · | 2020年5月5日 A | 23,451 | 0 | 0 | $0 |
| Thomas J Lynch | · | 2004年11月2日 A | 5,000 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
ETF保有状況 36のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.64% | 42,246 NS | 2026年7月31日 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0.59% | 46,432 SH | 2026年10月2日 | 日次 |
| RZG · Invesco Exchange-Traded Fund Trust | 0.40% | 21,951 SH | 2026年10月2日 | 日次 |
| EBIT · Harbor ETF Trust | 0.25% | 1,133 NS | 2026年7月31日 | N-PORT |
| ESSC · Strategy Shares | 0.17% | 2,304 NS | 2026年7月31日 | N-PORT |
| IHI · iShares Trust | 0.16% | 203,954 SH | 2026年9月11日 | 日次 |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.10% | 50,848 SH | 2026年8月19日 | 日次 |
| IWO · iShares Trust | 0.07% | 429,440 SH | 2026年9月11日 | 日次 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.06% | 49,054 SH | 2026年8月19日 | 日次 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.05% | 148,966 SH | 2026年8月19日 | 日次 |
| RSSL · Global X Funds | 0.04% | 21,860 NS | 2026年7月31日 | N-PORT |
| ISCG · iShares Trust | 0.04% | 14,453 SH | 2026年9月11日 | 日次 |
| IWM · iShares Trust | 0.04% | 1,164,969 SH | 2026年9月11日 | 日次 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.03% | 263,046 SH | 2026年8月19日 | 日次 |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.03% | 23,979 SH | 2026年10月2日 | 日次 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 30,302 SH | 2026年10月2日 | 日次 |
| DFAS · Dimensional ETF Trust | 0.02% | 124,676 NS | 2026年7月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 20,435 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 495,296 SH | 2026年8月19日 | 日次 |
| VHT · VANGUARD WORLD FUND | 0.01% | 127,662 SH | 2026年8月19日 | 日次 |
| WSML · iShares Trust | 0.01% | 2,287 SH | 2026年9月11日 | 日次 |
| DXUV · Dimensional ETF Trust | 0.01% | 1,400 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 90,038 NS | 2026年7月31日 | N-PORT |
| TILT · FlexShares Trust | 0.00% | 3,634 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 4,761 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 9,530 NS | 2026年7月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 13,831 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 61,878 SH | 2026年9月11日 | 日次 |
| IWV · iShares Trust | 0.00% | 10,858 SH | 2026年9月11日 | 日次 |
| DFAT · Dimensional ETF Trust | 0.00% | 2,692 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,463,340 SH | 2026年8月19日 | 日次 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,652 SH | 2026年8月19日 | 日次 |
| IJR · iShares Trust | · | 2,603,782 SH | 2026年9月10日 | 日次 |
| IJT · iShares Trust | · | 403,685 SH | 2026年9月9日 | 日次 |
| XJR · iShares Trust | · | 5,899 SH | 2026年9月2日 | 日次 |
| ISCB · iShares Trust | · | 2,111 SH | 2026年9月11日 | 日次 |
AORT アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
レーティング · 14 アナリスト
買い
中央値ターゲット
$42.00
+88.3%
5 35.7%
強い買い
8 57.1%
買い
1 7.1%
保有
0 0.0%
売り
0 0.0%
強い売り
12ヶ月目標株価
8 アナリスト · 2026-09-29平均値ターゲット $42.15 +88.9%
← 全目標を下回る
現在価格 $22.31
安値$38.00
平均値$42.15
高値$48.00
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
FY基準、価格は各社の直近年度末終値。
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| IART | · | -1.8 | 1.5% | -31.6% | -49.6% | · |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| BBNX | $1.35B | -16.8 | 53.9% | -73.0% | -24.9% | 55.4% |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| CBLL | $822M | -15.0 | 36.1% | -60.0% | -32.6% | 87.9% |
| SIBN | $861M | -44.8 | 20.2% | -9.4% | -10.9% | 79.6% |
| VREX | $498M | -7.0 | 4.1% | -8.3% | -14.0% | 34.4% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
最新ニュース この会社に言及した最近の見出し
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
重視する指標を選択してください — 上記の「財務諸表」の任意の行の横にある「+」をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
出典：SEC 10-Q 提出日 8月 7, 2026